Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Most patients with pernicious anaemia require lifelong treatment, and maintaining consistent therapy prevents recurrence of potentially serious complications
Rodrguez Cetina Biefer H, et al
View B12 location details Bronx 2063A Bartow Ave, Bronx, NY 10475 A Bronx location focused on same-day practical testing workflows and result follow-up
US$ 22.97
US$ 26.40
US$ 25.68
